China Isotope & Radiation Subsidiary CNGT Seeks Investors for 20% Stake via Public Tender

• China Isotope & Radiation Corporation subsidiary CNGT launched a public tender for a capital increase on October 21, 2026.
• The proposed issuance comprises 17,645,851 new shares, representing a 20% equity interest in CNGT.
• The parent’s 93.15% stake would be diluted, but it expects to retain control of CNGT.
• Proceeds would fund research and production facilities, capacity expansion and working capital.
• Prospective investors must deposit at least 30% of their proposed investment before November 18, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Isotope & Radiation Corporation published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261021-12378716), on October 21, 2026, and is solely responsible for the information contained therein.